MONTREAL, July 27, 2015 /CNW/ -- Inocucor Technologies Inc., the agriculture biotech company that produces sustainable biological accelerators for farmers, has received a notice of allowance from the U.S. Patent and Trademark Office for its patent application to protect Inocucor consortia and unique microbial products that accelerate plant growth and enhance yields on farms and in greenhouses.
This initial patent relates to Inocucor's live IN-M1 microbial consortium and its fermentation byproducts, which are the basis of the formulation for Inocucor Garden Solution™, the company's first-generation growth-accelerator product. Garden Solution is formulated to naturally sustain robust plant growth, increase plant vigor and actively build a friable and rich soil, improving the health of the entire phyto-microbiome.
The patent applies to each of the individual Inocul-M™ microorganisms characterized by Inocucor and in other task-specific live consortia like IN-M1. Also protected are the biological ingredients produced during Inocucor's multi-species manufacturing process.
"Inocucor pioneered this proprietary fermentation process that combines natural bacteria and yeasts into powerful living growth stimulants for soil, seeds and plants," said Dr. Margaret Bywater-Ekegärd, co-founder and executive vice president of technology and innovation at Inocucor. "It is the first of numerous patents we expect to be granted for our unique approach to processes and products for bio-stimulation, bio-fertility and bio-protection."
Inocucor's protection extends to the delivery of these compositions to any plant part, above or below ground, anywhere a plant grows—in a farm field or in a greenhouse--including seeds and fruit. Protection covers all types of growing systems, including vertical farming, aeroponic and hydroponic systems. This means that Inocucor's Garden Solution is now available as a proprietary technology for the protection of natural ingredient production, whether it be for cultivation of specialty food crops and high-value produce or in formulations together with plant nutrients.
Based in Montreal, Inocucor produces sustainable bio-based products that improve crop yields, shorten growing periods and create healthier, more resilient soils for organic farmers, greenhouse growers and mainstream production farmers. Its core technology was developed in 2007 by Dr. Bywater–Ekegärd and Ananda Lynn Fitzsimmons, who believed that microbial, rather than chemical, solutions would be needed to help farmers feed a growing world population.
Inocucor recently opened a new headquarters and lab in Montreal's bioscience corridor that is compliant with current Good Manufacturing Practices (cGMPs) for the food industry. It has attracted collaborators from both the private and academic sectors in Canada and the U.S.
Inocucor has received two rounds of venture capital from Cycle Capital Management, a respected Canadian venture capital firm focused on the clean-tech sector. In early February 2015, Inocucor closed an interim round of financing from Cycle Capital Management with participation from Desjardins-Innovatech, the venture capital unit of one of North America's leading financial institutions, and most recently with two US-based family offices.
The company recently launched its Series B equity financing, on the order of $15 million, and expects its completion during the second half of 2015.
Contact: Michele Wells, Wells Communications, 303-417-0696
SOURCE Inocucor Technologies Inc.